Abstract 4500: Exploring site-specific activation of kinase inhibitors via AKR1C3-mediated prodrug strategy
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: Stanford Medicine, Stanford University
Language: English
Topic: Aldose Reductase and Taurine
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409632194
